Adverum Biotechnologies, Inc. (0HA3.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 02:58PM BST. Market open.
| Previous close | 1.5200 |
| Open | 1.5700 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 1.5700 - 1.5900 |
| 52-week range | 1.5700 - 1.5900 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 127.604M |
| Beta (5Y monthly) | 1.00 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5200 |
| Earnings date | 28 Feb 2022 - 04 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Quite a few insiders invested in Adverum Biotechnologies, Inc. (NASDAQ:ADVM) last year which is positive news for shareholders
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
- Zacks
Adverum (ADVM) Completes IND Amendment for Gene Therapy Study
Adverum (ADVM) completes IND amendment with the FDA for initiating the phase II LUNA study on its gene therapy candidate, ADVM-022, for treating wet-age-related macular degeneration. Stock up.
- Simply Wall St.
How Much Of Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Do Institutions Own?
A look at the shareholders of Adverum Biotechnologies, Inc. ( NASDAQ:ADVM ) can tell us which group is most powerful...
© 2022 Yahoo. All rights reserved.
